Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
29,149,043
-
Total 13F shares
-
13,270,111
-
Share change
-
+330,821
-
Total reported value
-
$444,423,457
-
Put/Call ratio
-
0%
-
Price per share
-
$33.50
-
Number of holders
-
144
-
Value change
-
+$17,779,306
-
Number of buys
-
79
-
Number of sells
-
51
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2016
As of 31 Dec 2016,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
144 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,270,111 shares.
The largest 10 holders included
BlackRock Fund Advisors, Krensavage Asset Management, LLC, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, FIRST MANHATTAN CO, and BlackRock Institutional Trust Company, N.A..
This page lists
144
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.